Frankfurt - Delayed Quote EUR

Solvonis Therapeutics plc (J4I.F)

Compare
0.0005
0.0000
(0.00%)
At close: 8:01:36 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
5/31/2021
Total Assets
2,434.0000
4,939.0000
3,130.0000
2,569.0000
Total Liabilities Net Minority Interest
408.0000
385.0000
2,318.0000
1,322.0000
Total Equity Gross Minority Interest
2,026.0000
4,554.0000
812.0000
1,247.0000
Total Capitalization
2,026.0000
4,554.0000
812.0000
1,247.0000
Common Stock Equity
2,026.0000
4,554.0000
812.0000
1,247.0000
Capital Lease Obligations
34.0000
22.0000
--
--
Net Tangible Assets
-42.0000
2,486.0000
-1,256.0000
-821.0000
Working Capital
-72.0000
1,790.0000
-1,578.0000
-1,197.0000
Invested Capital
2,026.0000
4,554.0000
1,770.0000
1,901.0000
Tangible Book Value
-42.0000
2,486.0000
-1,256.0000
-821.0000
Total Debt
34.0000
22.0000
958.0000
654.0000
Net Debt
--
--
360.0000
615.0000
Share Issued
104,097.2990
104,097.2990
104,097.2990
104,097.2990
Ordinary Shares Number
104,097.2990
104,097.2990
104,097.2990
104,097.2990
5/31/2021 - 1/19/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade